UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000007636
Receipt number R000009008
Scientific Title Phase II study of trastuzumab with irinotecan in HER2-positive metastatic or advanced gastric cancer patients previously treated with trastuzumab and failed
Date of disclosure of the study information 2012/04/01
Last modified on 2022/09/18 17:39:14

No. Disposal Last modified on Item of update
1 Insert 2012/04/01 17:30:17
2 Update 2014/04/01 19:48:49 Email
Last name of contact person
Last name of contact person
Email
3 Update 2015/04/15 21:40:27 Recruitment status
4 Update 2022/09/18 17:29:38 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Name of primary person or sponsor
Organization
Organization
Organization
Address
Address
Tel
Email
5 Update 2022/09/18 17:34:46 URL releasing protocol
Publication of results
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures
6 Update 2022/09/18 17:37:30 Recruitment status
Date of IRB
7 Update 2022/09/18 17:39:14 Date of the first journal publication of results